ViroGates A/S (CO:VIRO) — Market Cap & Net Worth
Market Cap & Net Worth: ViroGates A/S (VIRO)
ViroGates A/S (CO:VIRO) has a market capitalization of $13.80 Million (Dkr88.18 Million) as of July 22, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #26224 globally and #118 in its home market, demonstrating a -8.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ViroGates A/S's stock price Dkr9.50 by its total outstanding shares 9281891 (9.28 Million). Review VIRO free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
ViroGates A/S Market Cap History: 2018 to 2026
ViroGates A/S's market capitalization history from 2018 to 2026. Data shows change from $87.13 Million to $13.80 Million (-23.83% CAGR).
ViroGates A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ViroGates A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.14x
ViroGates A/S's market cap is 3.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $87.13 Million | $3.32 Million | -$16.99 Million | 26.28x | N/A |
| 2019 | $49.81 Million | $3.58 Million | -$18.80 Million | 13.91x | N/A |
| 2020 | $118.36 Million | $5.35 Million | -$18.74 Million | 22.11x | N/A |
| 2021 | $209.12 Million | $7.66 Million | -$17.66 Million | 27.31x | N/A |
| 2022 | $58.23 Million | $15.20 Million | -$9.65 Million | 3.83x | N/A |
| 2023 | $8.74 Million | $6.99 Million | -$12.10 Million | 1.25x | N/A |
| 2024 | $15.39 Million | $4.90 Million | -$14.35 Million | 3.14x | N/A |
Competitor Companies of VIRO by Market Capitalization
Companies near ViroGates A/S in the global market cap rankings as of July 22, 2026.
Key companies related to ViroGates A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #129 globally with a market cap of $173.31 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #199 globally with a market cap of $120.39 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #239 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #129 | Abbott Laboratories | NYSE:ABT | $173.31 Billion | $99.67 |
| #199 | Stryker Corporation | NYSE:SYK | $120.39 Billion | $314.58 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #239 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $82.35 |
ViroGates A/S Historical Marketcap From 2018 to 2026
Between 2018 and today, ViroGates A/S's market cap moved from $87.13 Million to $ 13.80 Million, with a yearly change of -23.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr13.80 Million | -29.37% |
| 2025 | Dkr19.53 Million | +26.89% |
| 2024 | Dkr15.39 Million | +76.08% |
| 2023 | Dkr8.74 Million | -84.99% |
| 2022 | Dkr58.23 Million | -72.15% |
| 2021 | Dkr209.12 Million | +76.69% |
| 2020 | Dkr118.36 Million | +137.61% |
| 2019 | Dkr49.81 Million | -42.83% |
| 2018 | Dkr87.13 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 22nd, 2026 the market cap of ViroGates A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.80 Million USD |
| MoneyControl | $13.80 Million USD |
| MarketWatch | $13.80 Million USD |
| marketcap.company | $13.80 Million USD |
| Reuters | $13.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ViroGates A/S
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic he… Read more